Aethlon Medical is a development stage medical device company focused on creating devices for the treatment of cancer, infectious diseases and other life-threatening conditions. The company’s Aethlon Hemopurifier is intended for the treatment of cancer, hepatitis-C virus, human immunodeficiency virus (HIF), and bioterror and pandemic threats. It also develops ELLSA to identify the presence of exosomes underlying the HIV, tuberculosis and various types of cancer. For further information, visit the company’s Web site at: www.aethlonmedical.com

EBD Group’s Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences. Investors and biopharmaceutical executives from around the world gather in San Francisco for this important event.

Let us hear your thoughts below: